Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B

NCT02618915 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision; not due to any safety concerns related to DTX101.

Conditions

Hemophilia B

Interventions

GENETIC: DTX101

Sponsor

Ultragenyx Pharmaceutical Inc